Hmmm...FridayAction...oldmanbadman rdncoic
Friday action is always different than the rest of the week. First the price will move up a little and then mostly, it will fall with the traders jumping back out for the weekend. If the buyers are still at it, then the price is not the point, but volume is. Why? Because the accumulaters hold their shares and buy more at any reduction in price.
Interested to see what happens today. Traders always watch the trend and follow it. Day traders are a different breed, they buy, sell, buy, sell, all day to make money on the point differences.
Been watching the insider selling and buying. Nothing. If a buyout is on the way they are not allowed to buy or sell in such a situation. Whatever happens, one thing is a given. People in the know buy low and then sell high depending on what their goals are. The old timers (Not Insiders) here are sitting on about 120% profit from their investments in BMRA. They know what is going on.
REMEMBER ONE THING! If you are invested in BMRA, you are sitting pretty and have at the very least, paper profits, if you haven't sold already. And the straphangers? Money talks, bullsheep walks. :) :) :) Comments from the cheap seats will be ignored. oldmanbadman rdncoic
Friday action is always different than the rest of the week. First the price will move up a little and then mostly, it will fall with the traders jumping back out for the weekend. If the buyers are still at it, then the price is not the point, but volume is. Why? Because the accumulaters hold their shares and buy more at any reduction in price.
Interested to see what happens today. Traders always watch the trend and follow it. Day traders are a different breed, they buy, sell, buy, sell, all day to make money on the point differences.
Been watching the insider selling and buying. Nothing. If a buyout is on the way they are not allowed to buy or sell in such a situation. Whatever happens, one thing is a given. People in the know buy low and then sell high depending on what their goals are. The old timers (Not Insiders) here are sitting on about 120% profit from their investments in BMRA. They know what is going on.
REMEMBER ONE THING! If you are invested in BMRA, you are sitting pretty and have at the very least, paper profits, if you haven't sold already. And the straphangers? Money talks, bullsheep walks. :) :) :) Comments from the cheap seats will be ignored. oldmanbadman rdncoic
Recent BMRA News
- Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 • GlobeNewswire Inc. • 04/29/2026 12:19:00 PM
- Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway • GlobeNewswire Inc. • 04/16/2026 12:19:00 PM
- Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs • GlobeNewswire Inc. • 04/14/2026 12:19:00 PM
- Biomerica Reports Third Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 04/13/2026 10:57:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/13/2026 09:15:20 PM
- Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe • GlobeNewswire Inc. • 03/18/2026 12:19:00 PM
- Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain • GlobeNewswire Inc. • 03/05/2026 01:19:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2026 10:15:26 PM
- Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy • GlobeNewswire Inc. • 02/26/2026 01:19:00 PM
- Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution • GlobeNewswire Inc. • 02/18/2026 01:19:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:40:25 PM
- Biomerica Reports Second Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 01/14/2026 10:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/14/2026 10:15:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2025 10:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2025 10:10:03 PM
- Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test • GlobeNewswire Inc. • 12/23/2025 01:19:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 01:19:33 PM
- Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio • GlobeNewswire Inc. • 12/11/2025 01:08:00 PM
- Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS • GlobeNewswire Inc. • 11/25/2025 01:19:00 PM
- Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand • GlobeNewswire Inc. • 11/06/2025 01:19:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/23/2025 08:15:04 PM
- Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. • GlobeNewswire Inc. • 10/16/2025 12:19:00 PM
- Biomerica Reports First Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 10/15/2025 01:27:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/14/2025 09:11:06 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/09/2025 09:15:26 PM
